MINAPHARM Pharmaceuticals (EGX: MIPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
161.54
0.00 (0.00%)
At close: Jan 29, 2025

MINAPHARM Pharmaceuticals Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1,7872,4081,8221,3039871,044
Upgrade
Market Cap Growth
-20.20%32.19%39.82%32.02%-5.49%-3.47%
Upgrade
Enterprise Value
4,3454,0872,6251,4481,1011,396
Upgrade
Last Close Price
161.54215.89145.12101.7775.1073.62
Upgrade
PE Ratio
--3.092.913.467.40
Upgrade
PS Ratio
0.400.620.500.430.420.51
Upgrade
PB Ratio
0.410.680.600.670.620.78
Upgrade
P/TBV Ratio
0.470.800.690.810.791.05
Upgrade
P/FCF Ratio
----3.44-
Upgrade
P/OCF Ratio
10.7722.793.246.292.265.07
Upgrade
EV/Sales Ratio
0.981.050.730.480.470.68
Upgrade
EV/EBITDA Ratio
6.987.632.421.731.773.87
Upgrade
EV/EBIT Ratio
12.4410.912.721.922.044.72
Upgrade
EV/FCF Ratio
-6.10---3.84-
Upgrade
Debt / Equity Ratio
1.271.080.800.640.600.66
Upgrade
Debt / EBITDA Ratio
9.046.712.221.491.542.47
Upgrade
Debt / FCF Ratio
----3.34-
Upgrade
Asset Turnover
-0.500.660.790.740.73
Upgrade
Inventory Turnover
-2.792.822.902.732.87
Upgrade
Quick Ratio
0.770.690.870.920.840.69
Upgrade
Current Ratio
1.161.141.461.611.341.22
Upgrade
Return on Equity (ROE)
-0.68%25.32%26.86%21.14%10.89%
Upgrade
Return on Assets (ROA)
-3.02%11.05%12.42%10.57%6.57%
Upgrade
Return on Capital (ROIC)
-3.66%13.92%16.41%14.07%8.36%
Upgrade
Earnings Yield
-10.65%-1.33%33.63%35.79%30.47%13.51%
Upgrade
FCF Yield
-39.83%-53.66%-32.85%-13.86%29.06%-3.67%
Upgrade
Dividend Yield
1.02%0.76%1.93%2.87%3.60%-
Upgrade
Payout Ratio
0.00%-9.43%10.68%29.33%67.42%
Upgrade
Buyback Yield / Dilution
0.80%3.57%6.67%---
Upgrade
Total Shareholder Return
1.82%4.34%8.60%2.87%3.60%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.